A two-part phase I study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonization of Staphylococcus aureus: A previously investigated 0.5 mg/g viscosified gel formulation versus a modified formulation.

Journal of Global Antimicrobial Resistance(2020)

引用 8|浏览11
暂无评分
摘要
•XF-73 led to a rapid reduction in semiquantitative Staphylococcus aureus scores.•Common treatment-related adverse events were rhinorrhoea and nasal dryness.•XF-73 demonstrated safety, tolerability and minimal side effects in healthy volunteers.
更多
查看译文
关键词
Staphylococcus aureus,Decolonisation,XF-73,Antimicrobial resistance
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要